AU557980B2 - Perfluorohydrocarbons as vehicles for drugs - Google Patents

Perfluorohydrocarbons as vehicles for drugs

Info

Publication number
AU557980B2
AU557980B2 AU13138/83A AU1313883A AU557980B2 AU 557980 B2 AU557980 B2 AU 557980B2 AU 13138/83 A AU13138/83 A AU 13138/83A AU 1313883 A AU1313883 A AU 1313883A AU 557980 B2 AU557980 B2 AU 557980B2
Authority
AU
Australia
Prior art keywords
perfluorohydrocarbons
vehicles
drugs
therapeutic drugs
administering therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU13138/83A
Other languages
English (en)
Other versions
AU1313883A (en
Inventor
Billie Murray York
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU1313883A publication Critical patent/AU1313883A/en
Application granted granted Critical
Publication of AU557980B2 publication Critical patent/AU557980B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU13138/83A 1982-04-05 1983-04-05 Perfluorohydrocarbons as vehicles for drugs Ceased AU557980B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36553982A 1982-04-05 1982-04-05
US365539 1982-04-05

Publications (2)

Publication Number Publication Date
AU1313883A AU1313883A (en) 1983-10-13
AU557980B2 true AU557980B2 (en) 1987-01-15

Family

ID=23439275

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13138/83A Ceased AU557980B2 (en) 1982-04-05 1983-04-05 Perfluorohydrocarbons as vehicles for drugs

Country Status (12)

Country Link
EP (1) EP0091313B1 (en, 2012)
KR (1) KR880002038B1 (en, 2012)
AT (1) ATE56138T1 (en, 2012)
AU (1) AU557980B2 (en, 2012)
CA (1) CA1295948C (en, 2012)
DE (1) DE3381854D1 (en, 2012)
GR (1) GR78151B (en, 2012)
IE (1) IE56412B1 (en, 2012)
IL (1) IL68456A (en, 2012)
NZ (1) NZ203802A (en, 2012)
PT (1) PT76504B (en, 2012)
WO (1) WO1983003544A1 (en, 2012)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8320264A (nl) * 1982-08-17 1984-07-02 Sun Tech Inc Perfluorkoolstof-emulsies, hun bereiding en hun toepassing in de therapie.
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
WO1993009833A1 (en) * 1991-11-14 1993-05-27 Alliance Pharmaceutical Corp. Method and apparatus for partial liquid ventilation using fluorocarbons
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
EP0664705B1 (en) * 1993-08-18 2000-10-04 Alcon Laboratories, Inc. Compositions of ergoline derivatives for the treatment of glaucoma
ATE206441T1 (de) 1994-03-04 2001-10-15 Univ Washington Block- und pfropfcopolymere und dazu gehöriges verfahren
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
DK1452171T3 (da) * 2000-10-13 2010-04-06 Nova Bio Pharma Technologies Ltd Farmaceutiske væskesuspensioner
CN100339066C (zh) * 2000-10-13 2007-09-26 剑桥生物稳定性有限公司 稳定的注射液组合物和方法
DE102006040450B3 (de) * 2006-08-24 2008-04-24 Coty Prestige Lancaster Group Gmbh Verwendung einer Zusammensetzung für die Hautbehandlung nach Röntgenbestrahlung
WO2014041071A1 (en) * 2012-09-12 2014-03-20 Novaliq Gmbh Semifluorinated alkane compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
BE629985A (en, 2012) * 1962-11-29
US3490923A (en) * 1966-07-28 1970-01-20 Du Pont Aerosol propellant composition used in dispensing foods
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US3929662A (en) * 1973-12-18 1975-12-30 Wave Energy Systems Liquid or gas phase sterilizing and cleaning composition containing an aldehyde and a fluoro or perfluoro compound
US4187252A (en) * 1977-08-26 1980-02-05 Suntech, Inc. Tetramethylpentane blood substitutes
US4110474A (en) * 1977-08-26 1978-08-29 Suntech, Inc. Tetramethylpentane blood substitutes
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
JPH08221312A (ja) * 1995-02-14 1996-08-30 Hitachi Ltd メモリカード装置

Also Published As

Publication number Publication date
GR78151B (en, 2012) 1984-09-26
EP0091313A3 (en) 1985-05-22
IE830776L (en) 1983-10-05
NZ203802A (en) 1985-07-31
WO1983003544A1 (en) 1983-10-27
EP0091313A2 (en) 1983-10-12
PT76504A (en) 1983-05-01
IL68456A0 (en) 1983-07-31
IE56412B1 (en) 1991-07-31
CA1295948C (en) 1992-02-18
KR880002038B1 (ko) 1988-10-13
AU1313883A (en) 1983-10-13
PT76504B (en) 1986-02-27
EP0091313B1 (en) 1990-09-05
ATE56138T1 (de) 1990-09-15
KR840004366A (ko) 1984-10-15
DE3381854D1 (de) 1990-10-11
IL68456A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
AU557980B2 (en) Perfluorohydrocarbons as vehicles for drugs
DE3779053D1 (en, 2012)
AU1840683A (en) Tilt bed for traction
AU570013B2 (en) Medicament inhaler
AU544440B2 (en) Therapeutic drug assay
AU4690379A (en) Administering intravenous drugs
AU545437B2 (en) 2-amino-6-trifluoromethoxy-benzothiazole medicament
AU566510B2 (en) Pharmaceutical 1,4-benzodiazepine-2-ones
AU2587988A (en) Syringe for one sole use
FI822683A7 (fi) Inertti täyteaine lääkeaineseosta varten.
AU1308988A (en) Therapeutic compositions
AU590783B2 (en) Therapeutic agent for treating hematopoietic diseases
DE3874610D1 (en, 2012)
AU7080587A (en) Therapeutic compositions for veterinary use
AU524257B2 (en) Imidazolylpyridine therapeutic agents
AU561449B2 (en) Pharmaceutical 3-aryl-7-chloro-9-oxo-3,4-dihyroacridines
AU2345988A (en) Pharmaceutical composition for piperidinoalkanol-decongestant combination
EP0303687A4 (en) COMPOSITIONS FOR IMPROVING ADCC THERAPIES.
AU7071487A (en) Chlorpheniramine therapy
AU567299B2 (en) Anthelmintics
SG46249A1 (en) Novel phospholipid derivatives
AU588467B2 (en) Novel therapeutic agent for gastritis
AU565613B2 (en) Nasal pharmaceutical composition
ZA832489B (en) Perfluorohydrocarbons as vehicles for administering drugs
AU1705783A (en) Medicine for the treatment of the neoplazic disease